| Managing COVID-19 in the oncology clinic and avoiding the distraction effect F Cortiula, A Pettke, M Bartoletti, F Puglisi, T Helleday Annals of oncology 31 (5), 553-555, 2020 | 206 | 2020 |
| Mucosal injury during anti-cancer treatment: from pathobiology to bedside D Basile, P Di Nardo, C Corvaja, SK Garattini, G Pelizzari, C Lisanti, ... Cancers 11 (6), 857, 2019 | 123 | 2019 |
| The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients D Basile, A Parnofiello, MG Vitale, F Cortiula, L Gerratana, V Fanotto, ... Journal of cachexia, sarcopenia and muscle 10 (2), 368-377, 2019 | 76 | 2019 |
| Platinum salts in patients with breast cancer: a focus on predictive factors M Garutti, G Pelizzari, M Bartoletti, MC Malfatti, L Gerratana, G Tell, ... International Journal of Molecular Sciences 20 (14), 3390, 2019 | 62 | 2019 |
| Lactate dehydrogenase (LDH) response to first-line treatment predicts survival in metastatic breast cancer: first clues for a cost-effective and dynamic biomarker G Pelizzari, D Basile, S Zago, C Lisanti, M Bartoletti, L Bortot, MG Vitale, ... Cancers 11 (9), 1243, 2019 | 52 | 2019 |
| Bevacizumab or PARP-inhibitors maintenance therapy for platinum-sensitive recurrent ovarian cancer: a network meta-analysis M Bartoletti, G Pelizzari, L Gerratana, L Bortot, D Lombardi, M Nicoloso, ... International Journal of Molecular Sciences 21 (11), 3805, 2020 | 35 | 2020 |
| Post-neoadjuvant strategies in breast cancer: From risk assessment to treatment escalation G Pelizzari, L Gerratana, D Basile, V Fanotto, M Bartoletti, A Liguori, ... Cancer Treatment Reviews 72, 7-14, 2019 | 29 | 2019 |
| Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study D Basile, M Bartoletti, M Polano, L Bortot, L Gerratana, P Di Nardo, ... Clinical Nutrition 40 (1), 286-294, 2021 | 28 | 2021 |
| Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis L Gerratana, D Basile, B Toffoletto, M Bulfoni, S Zago, A Magini, M Lera, ... Scientific Reports 10 (1), 7010, 2020 | 22 | 2020 |
| Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study: complementary and alternative medicine in oncology C Bozza, L Gerratana, D Basile, MG Vitale, M Bartoletti, E Agostinetto, ... Journal of cancer research and clinical oncology 144, 2029-2047, 2018 | 17 | 2018 |
| Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva M Bartoletti, R Mazzeo, M De Scordilli, A Del Fabro, MG Vitale, L Bortot, ... International Journal of Gynecologic Cancer 30 (11), 2020 | 15 | 2020 |
| The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancer C Lisanti, D Basile, A Parnofiello, E Bertoli, VJ Andreotti, SK Garattini, ... Journal of geriatric oncology 11 (8), 1268-1273, 2020 | 11 | 2020 |
| A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer S Gagno, E Poletto, M Bartoletti, L Quartuccio, C Romualdi, M Garziera, ... Gynecologic Oncology 156 (1), 233-242, 2020 | 5 | 2020 |
| Long-term toxicity profile of trastuzumab emtansine (T-DM1): A multicenter real-life study. G Buono, A Fabi, L Del Mastro, K Cannita, NM La Verde, R Ardito, ... Journal of Clinical Oncology 37 (15_suppl), e12507-e12507, 2019 | 5 | 2019 |
| Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey M Bonotto, D Basile, L Gerratana, G Pelizzari, M Bartoletti, MG Vitale, ... The Breast 40, 45-52, 2018 | 5 | 2018 |
| Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study M Bonotto, D Basile, L Gerratana, M Bartoletti, C Lisanti, G Pelizzari, ... Future Oncology 16 (27), 2059-2073, 2020 | 3 | 2020 |
| Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World G Pelizzari, F Cortiula, M Giavarra, M Bartoletti, C Lisanti, V Buoro, ... Drugs & Aging 37, 677-689, 2020 | 3 | 2020 |
| Pharmacogenetic score predicts overall survival, progression-free survival and platinum sensitivity in ovarian cancer S Gagno, M Bartoletti, C Romualdi, E Poletto, S Scalone, R Sorio, ... Pharmacogenomics 21 (14), 995-1010, 2020 | 2 | 2020 |
| Cachexia and malnutrition in cancer patients: inflammation indexes evaluation and nutritional intervention M Borghi, M Bartoletti, D Basile, CA Bertuzzi, S Bodecchi, L Bortot, ... Nutrition 65, 2-3, 2019 | 2 | 2019 |
| Role of anthracyclines in neoadjuvant anti-HER2 regimens for HER2+ breast cancer (BC): A network meta-analysis (NMA). G Pelizzari, L Gerratana, D Basile, M Bartoletti, C Lisanti, SK Garattini, ... Journal of Clinical Oncology 37 (15_suppl), 577-577, 2019 | 2 | 2019 |
